CircUGGT2 downregulation by METTL14-dependent m6A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p/MAP3K9 axis.

[1]  Zhen-Chang Sun,et al.  PRMT3‐Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma , 2023, Advanced science.

[2]  Y. Zhang,et al.  CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy‐dependent ferroptosis , 2023, Journal of cellular physiology.

[3]  Fan Yang,et al.  Inhibition of JNK/c-Jun-ATF2 Overcomes Cisplatin Resistance in Liver Cancer through down-Regulating Galectin-1 , 2023, International journal of biological sciences.

[4]  Xu Zhou,et al.  Non-coding RNAs regulating mitochondrial function in cardiovascular diseases , 2023, Journal of Molecular Medicine.

[5]  M. Zhang,et al.  METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance. , 2022, Cancer letters.

[6]  Xu Zhou,et al.  Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications , 2022, Frontiers in Oncology.

[7]  D. Drewry,et al.  MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. , 2022, Frontiers in bioscience.

[8]  Lin-lin Tan,et al.  Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9 , 2022, Acta Pharmacologica Sinica.

[9]  Zhe Zhang,et al.  METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma , 2022, Cell Communication and Signaling.

[10]  Hua Xiao,et al.  The N6-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p/PGF signalling pathway , 2022, Molecular cancer.

[11]  P. Yi,et al.  Targeting the RNA m6A modification for cancer immunotherapy , 2022, Molecular cancer.

[12]  Zhiyong Zhang,et al.  Hsa-miR-186-3p suppresses colon cancer progression by inhibiting KRT18/MAPK signaling pathway , 2022, Cell cycle.

[13]  Fu Chen,et al.  Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9. , 2022, Neoplasma.

[14]  Xiaoyu Chen,et al.  METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis , 2022, Molecular cancer.

[15]  Quan P. Ly,et al.  Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  Jian Peng,et al.  M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma , 2022, Molecular cancer.

[17]  J. Kjems,et al.  The emerging roles of circRNAs in cancer and oncology , 2021, Nature Reviews Clinical Oncology.

[18]  Shicheng Yu,et al.  METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination , 2021, Molecular therapy. Nucleic acids.

[19]  R. Xu,et al.  The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p , 2021, Molecular cancer.

[20]  Yanjie Wei,et al.  A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression , 2021, Molecular Cancer.

[21]  Chao Huang,et al.  Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer , 2021, Cancer Research.

[22]  K. Tao,et al.  CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition , 2021, Journal of Experimental & Clinical Cancer Research.

[23]  Yu Zhang,et al.  CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability , 2021, Molecular cancer.

[24]  Xiaoyu Liu,et al.  MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1 , 2021, World Journal of Surgical Oncology.

[25]  L. Xing,et al.  The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC , 2021, Molecular cancer.

[26]  Zekuan Xu,et al.  A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling , 2021, Molecular cancer.

[27]  H. Fan,et al.  The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner , 2021, Frontiers in Cell and Developmental Biology.

[28]  Wenxin Qin,et al.  circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity , 2021, Nature communications.

[29]  Zhengjie Huang,et al.  Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation , 2021, OncoTargets and therapy.

[30]  Xiaoyu Liu,et al.  miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway , 2021, Bioengineered.

[31]  Hanchen Xu,et al.  CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis , 2020, Journal of experimental & clinical cancer research : CR.

[32]  Jun Yu,et al.  RNA m6A methyltransferase METTL3 facilitates colorectal cancer by activating m6A-GLUT1-mTORC1 axis and is a therapeutic target. , 2020, Gastroenterology.

[33]  Guoxin Zhang,et al.  circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2 , 2020, Molecular cancer.

[34]  Huimian Xu,et al.  Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy , 2020, BMC Gastroenterology.

[35]  Zheng Li,et al.  Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway , 2020, Journal of experimental & clinical cancer research : CR.

[36]  S. Park,et al.  S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial. , 2020, The Lancet. Oncology.

[37]  Yu-qin Pan,et al.  METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer , 2020, Molecular Cancer.

[38]  Yue Huang,et al.  Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. , 2020, Cancer cell.

[39]  Chuan He,et al.  RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. , 2020, Cell stem cell.

[40]  M. Zheng,et al.  METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST , 2020, Molecular Cancer.

[41]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[42]  Xiaoqing Wu,et al.  circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer , 2019, Molecular Cancer.

[43]  Kai Huang,et al.  Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation , 2019, Molecular Cancer.

[44]  Yan Lu,et al.  CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer , 2019, Molecular Cancer.

[45]  Yongjie Zhang,et al.  Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression , 2019, Molecular Cancer.

[46]  Q. Ding,et al.  METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance , 2019, Gut.

[47]  Kun Wang,et al.  Biogenesis, functions and clinical significance of circRNAs in gastric cancer , 2019, Molecular Cancer.

[48]  Yifen Zhang,et al.  Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. , 2019, Cancer letters.

[49]  Xiaoyu Chen,et al.  The role of m6A RNA methylation in human cancer , 2019, Molecular Cancer.

[50]  Xiaoyu Chen,et al.  CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling , 2019, Molecular Cancer.

[51]  Qiang Zhang,et al.  Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression , 2019, Molecular Cancer.

[52]  Zekuan Xu,et al.  Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway , 2019, Molecular Cancer.

[53]  Hui Liu,et al.  Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis , 2018, Molecular Cancer.

[54]  Jun Xia,et al.  miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer , 2018, Molecular therapy. Nucleic acids.

[55]  Jie Han,et al.  Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression , 2018, Molecular Cancer.

[56]  H. Ishii,et al.  The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. , 2017, International journal of oncology.

[57]  Hui Liu,et al.  Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression , 2017, Molecular Cancer.

[58]  J. Ajani,et al.  A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  Jie He,et al.  Cancer incidence and mortality in China, 2013. , 2017, Cancer letters.

[60]  Hecheng Zhou,et al.  CircRNA: functions and properties of a novel potential biomarker for cancer , 2017, Molecular Cancer.

[61]  Zhike Lu,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[62]  Feng Liu,et al.  METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6‐methyladenosine‐dependent primary MicroRNA processing , 2017, Hepatology.

[63]  R. Gregory,et al.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. , 2016, Molecular cell.

[64]  N. Hayward,et al.  Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors , 2014, Nature Communications.